Document Detail


Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA.
MedLine Citation:
PMID:  16230903     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We sought to develop and validate a pharmacokinetic model allowing description of the magnetic resonance (MR) signal intensity induced by the hepatobiliary contrast agent Gd-BOPTA and to quantify the overall Gd-BOPTA transport in rat liver. MATERIALS AND METHODS: MR signal intensity was recorded during the perfusion of rat livers with Gd-DTPA, an extracellular contrast agent, and Gd-BOPTA, a hepatobiliary contrast agent. Similar experiments were conducted with Gd-labeled contrast agents for quantitative measurement in liver, bile and perfusate. RESULTS: A complete 6-compartment, 8 parameter open model was first developed to describe the pharmacokinetics of the compound based on the radioactivity data analysis. Because perfusate and bile data were not available in MRI experiments, a reduced model (6-compartment, 5 parameters) was considered for the MRI data. The performance of the reduced model was tested using the radioactivity data. The reduced model successfully described the contrast agent amount in the liver and correctly predicted amounts in bile and perfusate. CONCLUSIONS: Pharmacokinetic modeling of MR signal intensity induced by Gd-BOPTA permits quantification of Gd-BOPTA uptake and biliary excretion in rat livers.
Authors:
Corinne Planchamp; Catherine M Pastor; Luc Balant; Christoph D Becker; François Terrier; Marianne Gex-Fabry
Related Documents :
7914403 - Intestinal clearance of h2-antagonists.
21452373 - Black tea prevents high fat diet-induced non-alcoholic steatohepatitis.
7472783 - Ultrastructure of rat pulmonary arterioles after neonatal exposure to hypoxia and subse...
Publication Detail:
Type:  Journal Article; Validation Studies    
Journal Detail:
Title:  Investigative radiology     Volume:  40     ISSN:  0020-9996     ISO Abbreviation:  Invest Radiol     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-10-18     Completed Date:  2006-01-12     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  705-14     Citation Subset:  IM    
Affiliation:
Department of Radiology, Geneva University Hospitals, Geneva, Switzerland. corinne.planchamp@hcuge.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bile / metabolism*
Biological Transport
Contrast Media / pharmacokinetics*
Extracellular Space / metabolism
Gadolinium DTPA / pharmacokinetics*
Liver / metabolism*
Magnetic Resonance Imaging
Meglumine / analogs & derivatives*,  pharmacokinetics
Models, Biological
Organometallic Compounds / pharmacokinetics*
Perfusion
Rats
Rats, Sprague-Dawley
Reproducibility of Results
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Organometallic Compounds; 113662-23-0/gadobenic acid; 6284-40-8/Meglumine; 80529-93-7/Gadolinium DTPA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A feasibility study of contrast enhancement of acute myocardial infarction in multislice computed to...
Next Document:  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field streng...